Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

9.54
Delayed Data
As of Sep 28
 -0.05 / -0.52%
Today’s Change
4.50
Today|||52-Week Range
11.69
+41.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues24.2M5.9M8.1M6.2M
 
 
 
 
 
Depreciation And Amortization497.8K526.9K597.4K786.5K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.0M19.9M23.0M24.6M
 
 
 
 
 
Research And Development16.1M15.6M18.2M19.6M
 
 
 
 
 
Total Operating Expenses20.5M20.5M23.6M25.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.7M-14.5M-15.5M-19.2M
 
 
 
 
 
Extraordinary Charge-140.2K-3.5M-406.2K-113.8K
 
 
 
 
 
Other Expenses215.0K-194.5K7.8M635.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.8M-18.3M-8.0M-18.7M
 
 
 
 
 
Income Taxes-1.8M-308.5K0.000.00
 
 
 
Net Income5.6M-18.0M-8.0M-18.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS72.0M72.2M72.2M73.0M
 
 
 
 
 
Shares To Calculate EPS Diluted74.0M72.2M72.2M73.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.07-$0.25-$0.11-$0.26
 
 
 
 
 
EPS Diluted$0.07-$0.25-$0.11-$0.26